Panagora Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-246,302
| Closed | -$4.42M | – | 2464 |
|
|
2017
Q4 | $4.42M | Buy |
246,302
+81,890
| +50% | +$1.01M | 0.02% | 590 |
|
|
2017
Q3 | $1.94M | Buy |
164,412
+44,407
| +37% | +$498K | 0.01% | 877 |
|
|
2017
Q2 | $1.26M | Buy |
120,005
+118,489
| +7,816% | +$1.21M | 0.01% | 1030 |
|
|
2017
Q1 | $17K | Hold |
1,516
| – | – | ﹤0.01% | 2214 |
|
|
2016
Q4 | $21K | Hold |
1,516
| – | – | ﹤0.01% | 2220 |
|
|
2016
Q3 | $19K | Hold |
1,516
| – | – | ﹤0.01% | 2269 |
|
|
2016
Q2 | $17K | Hold |
1,516
| – | – | ﹤0.01% | 2189 |
|
|
2016
Q1 | $17K | Sell |
1,516
-1,563
| -51% | -$19.8K | ﹤0.01% | 2164 |
|
|
2015
Q4 | $53K | Buy |
3,079
+1,563
| +103% | +$28K | ﹤0.01% | 1965 |
|
|
2015
Q3 | $30K | Sell |
1,516
-3,384
| -69% | -$77.6K | ﹤0.01% | 2086 |
|
|
2015
Q2 | $80K | Hold |
4,900
| – | – | ﹤0.01% | 2016 |
|
|
2015
Q1 | $76K | Sell |
4,900
-18,160
| -79% | -$282K | ﹤0.01% | 1995 |
|
|
2014
Q4 | $329K | Buy |
23,060
+16,631
| +259% | +$176K | ﹤0.01% | 1441 |
|
|
2014
Q3 | $42K | Sell |
6,429
-2,820
| -30% | -$18.7K | ﹤0.01% | 2061 |
|
|
2014
Q2 | $64K | Hold |
9,249
| – | – | ﹤0.01% | 2033 |
|
|
2014
Q1 | $66K | Hold |
9,249
| – | – | ﹤0.01% | 2027 |
|
|
2013
Q4 | $87K | Hold |
9,249
| – | – | ﹤0.01% | 1882 |
|
|
2013
Q3 | $58K | Buy |
9,249
+5,484
| +146% | +$34.3K | ﹤0.01% | 1994 |
|
|
2013
Q2 | $25K | Buy |
+3,765
| New | +$29.9K | ﹤0.01% | 2149 |
|
Other funds holding SCMP
Panagora Asset Management's SCMP Position: Q1 2018 in Review
Panagora Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 246,302 shares — an estimated $4.42M sold.
Panagora Asset Management first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $4.42M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Panagora Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Panagora Asset Management sold 246,302 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $4.42M.
- Panagora Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Panagora Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $4.42M in Q4 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Panagora Asset Management's 13F filing for Q1 2018, filed 15 May 2018.